KR20020000545A - 폴리사이클릭 티아졸계 및 식욕 억제제로서의 이의 용도 - Google Patents

폴리사이클릭 티아졸계 및 식욕 억제제로서의 이의 용도 Download PDF

Info

Publication number
KR20020000545A
KR20020000545A KR1020017010874A KR20017010874A KR20020000545A KR 20020000545 A KR20020000545 A KR 20020000545A KR 1020017010874 A KR1020017010874 A KR 1020017010874A KR 20017010874 A KR20017010874 A KR 20017010874A KR 20020000545 A KR20020000545 A KR 20020000545A
Authority
KR
South Korea
Prior art keywords
alkyl
phenyl
substituted
conh
ocf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020017010874A
Other languages
English (en)
Korean (ko)
Inventor
예네게르하르트
가이젠카를
랑한스-요헨
빅켈마르틴
Original Assignee
로버트 흐라이탁, 미쉘 베스트
아벤티스 파마 도이칠란트 게엠베하
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 로버트 흐라이탁, 미쉘 베스트, 아벤티스 파마 도이칠란트 게엠베하 filed Critical 로버트 흐라이탁, 미쉘 베스트
Publication of KR20020000545A publication Critical patent/KR20020000545A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/84—Naphthothiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020017010874A 1999-02-26 2000-02-05 폴리사이클릭 티아졸계 및 식욕 억제제로서의 이의 용도 Ceased KR20020000545A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19908533.1 1999-02-26
DE19908533A DE19908533A1 (de) 1999-02-26 1999-02-26 Polycyclische Thiazol-Systeme, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend diese Verbindungen
PCT/EP2000/000927 WO2000051997A1 (de) 1999-02-26 2000-02-05 Polycyclische thiazol-systeme und ihre verwendung als anorektika

Publications (1)

Publication Number Publication Date
KR20020000545A true KR20020000545A (ko) 2002-01-05

Family

ID=7899078

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017010874A Ceased KR20020000545A (ko) 1999-02-26 2000-02-05 폴리사이클릭 티아졸계 및 식욕 억제제로서의 이의 용도

Country Status (19)

Country Link
US (1) US6187801B1 (https=)
EP (1) EP1183247B1 (https=)
JP (1) JP4728485B2 (https=)
KR (1) KR20020000545A (https=)
CN (1) CN1149205C (https=)
AT (1) ATE296295T1 (https=)
AU (1) AU762802B2 (https=)
BR (1) BR0008511A (https=)
CA (1) CA2364903A1 (https=)
CO (1) CO5180595A1 (https=)
DE (2) DE19908533A1 (https=)
DK (1) DK1183247T3 (https=)
ES (1) ES2241574T3 (https=)
HK (1) HK1042300B (https=)
MY (1) MY133195A (https=)
PT (1) PT1183247E (https=)
TW (1) TW593294B (https=)
WO (1) WO2000051997A1 (https=)
ZA (1) ZA200106440B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100712171B1 (ko) * 2004-09-17 2007-05-02 김진우 폐타이어를 이용한 조립식 배관블록

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19908535A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas
NZ520981A (en) * 2000-02-26 2004-08-27 Aventis Pharma Gmbh 8,8a-dihydro-indeno[1,2-d]thiazole derivatives with a sulphonamido or sulphono substituent in the 2 position, a method for production thereof and use thereof as a medicament
DE10142663B4 (de) * 2001-08-31 2004-08-19 Aventis Pharma Deutschland Gmbh C2-Disubstituierte Indan-1-ol-Systeme
MX2010010659A (es) * 2008-03-31 2010-10-26 Genentech Inc Compuestos de benzopirano y benzoxepina, inhibidores de fosfoinoinositida 3-cinasas y metodos para utilizarlos.
US8263633B2 (en) 2009-09-28 2012-09-11 F. Hoffman-La Roche Ag Benzoxepin PI3K inhibitor compounds and methods of use
MY160064A (en) 2009-09-28 2017-02-15 Hoffmann La Roche Benzoxazepin pi3k inhibitor compounds and methods of use
US9090628B2 (en) 2011-03-21 2015-07-28 Genentech, Inc. Benzoxazepin compounds selective for PI3K P110 delta and methods of use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2640358A1 (de) * 1976-09-08 1978-03-16 Hoechst Ag Thiazolidinderivate und verfahren zu ihrer herstellung
EP0749966A4 (en) * 1994-03-11 1997-07-02 Yamanouchi Pharma Co Ltd 5-HT 3 RECEPTOR AGONIST, NEW THIAZOLE DERIVATIVE AND INTERMEDIATE FOR OBTAINING IT
JPH1179993A (ja) * 1997-09-05 1999-03-23 Sumitomo Pharmaceut Co Ltd 免疫抑制剤
DE19831878C2 (de) * 1998-07-17 2001-05-17 Aventis Pharma Gmbh Polycyclische Thiazolidin-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19908535A1 (de) * 1999-02-26 2000-08-31 Aventis Pharma Gmbh Verwendung von polycyclischen Thiazol-Systemen zur Herstellung von Medikamenten zur Prophylaxe oder Behandlung von Obesitas

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100712171B1 (ko) * 2004-09-17 2007-05-02 김진우 폐타이어를 이용한 조립식 배관블록

Also Published As

Publication number Publication date
DE19908533A1 (de) 2000-08-31
CO5180595A1 (es) 2002-07-30
DK1183247T3 (da) 2005-09-19
ATE296295T1 (de) 2005-06-15
US6187801B1 (en) 2001-02-13
HK1042300B (zh) 2004-12-10
HK1042300A1 (en) 2002-08-09
DE50010403D1 (de) 2005-06-30
PT1183247E (pt) 2005-07-29
CN1149205C (zh) 2004-05-12
JP2002538150A (ja) 2002-11-12
BR0008511A (pt) 2002-04-02
WO2000051997A1 (de) 2000-09-08
CN1341108A (zh) 2002-03-20
AU2441600A (en) 2000-09-21
EP1183247B1 (de) 2005-05-25
ES2241574T3 (es) 2005-11-01
MY133195A (en) 2007-10-31
JP4728485B2 (ja) 2011-07-20
AU762802B2 (en) 2003-07-03
TW593294B (en) 2004-06-21
CA2364903A1 (en) 2000-09-08
EP1183247A1 (de) 2002-03-06
ZA200106440B (en) 2002-03-06

Similar Documents

Publication Publication Date Title
JP3542078B2 (ja) インデノ−、ナフト−およびベンゾシクロヘプタジヒドロチアゾール誘導体、それらの製造ならびに食欲抑制薬としてのそれらの使用
CZ20022838A3 (cs) 8,8a-Dihydroindeno [1,2-d]thiazolové deriváty, substituované v poloze 8a, způsob jejich přípravy a jejich pouľití jako léčiv
JP4728482B2 (ja) 肥満症を予防または治療するための薬剤の製造における多環式チアゾール系の使用
JP4728483B2 (ja) 肥満の予防または治療のための医薬の製造のための多環２−アミノチアゾール系の使用
JP4728484B2 (ja) 多環２−アミノチアゾール系、その製造方法およびそれを含む医薬
RU2236405C2 (ru) Полициклические тиазолидин-2-илиденовые амины, содержащие их лекарственные средства и способ получения лекарственного средства
KR20020000545A (ko) 폴리사이클릭 티아졸계 및 식욕 억제제로서의 이의 용도
JP4658332B2 (ja) 多環２−アミノジヒドロチアゾール系、その製造方法および医薬としての使用
MXPA01007494A (en) Polycyclic thiazole systems and their utilization as anorectics
MXPA01007542A (es) Uso de sistemas de tiazol policiclico para producir medicamentos para prevenir o tratar obesidad
CZ20022837A3 (cs) Substituované 8,8a-dihydro-3aH-indeno[1,2-d]thiazoly, způsob jejich přípravy a jejich pouľití jako léčiv
MXPA01007281A (en) Polycyclic 2-amino-thiazole systems, method for the production thereof and medicament containing said compounds

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20010824

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20050128

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20060506

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20060926

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20060506

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I